Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review
Youjin Oh, Joo Hee Park, Trie Arni Djunadi, Zunairah Shah, Liam Il Young Chung, Young Kwang Chae*
Dive into the research topics of 'Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review'. Together they form a unique fingerprint.